Literature DB >> 19437621

Sp1 and Sp3 regulate transcription of the cyclin-dependent kinase 5 regulatory subunit 2 (p39) promoter in neuronal cells.

Alvaro Valin1, Julie D Cook, Sarah Ross, Christi L Saklad, Grace Gill.   

Abstract

Cyclin-dependent kinase 5 (cdk5) activity is critical for development and function of the nervous system. Cdk5 activity is dependent on association with the regulators p35 and p39 whose expression is highly regulated in the developing nervous system.We have identified a small 200 bp fragment of the p39 promoter that is sufficient for cell type-specific expression in neuronal cells. Mutational analysis revealed that a cluster of predicted binding sites for Sp1, AP-1/CREB/ATF and E box-binding transcription factors is essential for full activity of the p39 promoter. Electrophoretic mobility shift assays revealed that Sp1 and Sp3 bound to sequences required for p39 promoter function and chromatin immunoprecipitation assays confirmed binding of these proteins to the endogenous p39 promoter. Furthermore, depletion of either Sp1 or Sp3 by siRNA reduced expression from the p39 promoter. Our data suggest that the ubiquitously expressed transcription factors Sp1 and Sp3 regulate transcription of the cdk5 regulator p39 in neuronal cells, possibly in cooperation with tissue-specific transcription factors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19437621      PMCID: PMC2775520          DOI: 10.1016/j.bbagrm.2009.01.007

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  42 in total

Review 1.  Function and regulation of CREB family transcription factors in the nervous system.

Authors:  Bonnie E Lonze; David D Ginty
Journal:  Neuron       Date:  2002-08-15       Impact factor: 17.173

2.  Cloning by recognition site screening of two novel GT box binding proteins: a family of Sp1 related genes.

Authors:  G Hagen; S Müller; M Beato; G Suske
Journal:  Nucleic Acids Res       Date:  1992-11-11       Impact factor: 16.971

Review 3.  Induction and dorsoventral patterning of the telencephalon.

Authors:  S W Wilson; J L Rubenstein
Journal:  Neuron       Date:  2000-12       Impact factor: 17.173

4.  Mouse brain organization revealed through direct genome-scale TF expression analysis.

Authors:  Paul A Gray; Hui Fu; Ping Luo; Qing Zhao; Jing Yu; Annette Ferrari; Toyoaki Tenzen; Dong-In Yuk; Eric F Tsung; Zhaohui Cai; John A Alberta; Le-Ping Cheng; Yang Liu; Jan M Stenman; M Todd Valerius; Nathan Billings; Haesun A Kim; Michael E Greenberg; Andrew P McMahon; David H Rowitch; Charles D Stiles; Qiufu Ma
Journal:  Science       Date:  2004-12-24       Impact factor: 47.728

5.  Region-specific expression of cyclin-dependent kinase 5 (cdk5) and its activators, p35 and p39, in the developing and adult rat central nervous system.

Authors:  M Zheng; C L Leung; R K Liem
Journal:  J Neurobiol       Date:  1998-05

Review 6.  Transcription initiation from TATA-less promoters within eukaryotic protein-coding genes.

Authors:  S T Smale
Journal:  Biochim Biophys Acta       Date:  1997-03-20

7.  Temporal and spatial patterns of expression of p35, a regulatory subunit of cyclin-dependent kinase 5, in the nervous system of the mouse.

Authors:  I Delalle; P G Bhide; V S Caviness; L H Tsai
Journal:  J Neurocytol       Date:  1997-05

8.  Cooperation of Sp1 and p300 in the induction of the CDK inhibitor p21WAF1/CIP1 during NGF-mediated neuronal differentiation.

Authors:  N Billon; D Carlisi; M B Datto; L A van Grunsven; A Watt; X F Wang; B B Rudkin
Journal:  Oncogene       Date:  1999-05-06       Impact factor: 9.867

9.  Exonic Sp1 sites are required for neural-specific expression of the glycine receptor beta subunit gene.

Authors:  H Tintrup; M Fischer; H Betz; J Kuhse
Journal:  Biochem J       Date:  2001-04-01       Impact factor: 3.857

10.  Brn-1 and Brn-2 share crucial roles in the production and positioning of mouse neocortical neurons.

Authors:  Yoshinobu Sugitani; Shigeyasu Nakai; Osamu Minowa; Miyuki Nishi; Kou-Ichi Jishage; Hitoshi Kawano; Kensaku Mori; Masaharu Ogawa; Tetsuo Noda
Journal:  Genes Dev       Date:  2002-07-15       Impact factor: 11.361

View more
  9 in total

1.  Mithramycin A suppresses expression of the human melanoma-associated gene ABCB8.

Authors:  Iwona Sachrajda; Marcin Ratajewski
Journal:  Mol Genet Genomics       Date:  2010-11-03       Impact factor: 3.291

2.  Loss in efficacy measures of tolfenamic acid in a tau knock-out model: Relevance to Alzheimer's disease.

Authors:  Allison Leso; Syed W Bihaqi; Anwar Masoud; Joanna K Chang; Asma Lahouel; Nasser Zawia
Journal:  Exp Biol Med (Maywood)       Date:  2019-08-26

3.  The Cdk5 activator P39 specifically links muskelin to myosin II and regulates stress fiber formation and actin organization in lens.

Authors:  Brajendra K Tripathi; Douglas R Lowy; Peggy S Zelenka
Journal:  Exp Cell Res       Date:  2014-08-13       Impact factor: 3.905

4.  Tolfenamic acid reduces tau and CDK5 levels: implications for dementia and tauopathies.

Authors:  Lina Adwan; Gehad M Subaiea; Riyaz Basha; Nasser H Zawia
Journal:  J Neurochem       Date:  2014-10-18       Impact factor: 5.372

5.  Mithramycin A Alleviates Cognitive Deficits and Reduces Neuropathology in a Transgenic Mouse Model of Alzheimer's Disease.

Authors:  Chao Wei; Wei Zhang; Qiong Zhou; Chao Zhao; Ying Du; Qi Yan; Zhuyi Li; Jianting Miao
Journal:  Neurochem Res       Date:  2016-04-12       Impact factor: 3.996

6.  Enhanced taupathy and AD-like pathology in aged primate brains decades after infantile exposure to lead (Pb).

Authors:  Syed Waseem Bihaqi; Nasser H Zawia
Journal:  Neurotoxicology       Date:  2013-08-21       Impact factor: 4.294

7.  Differential effects on neurodevelopment of FTO variants in obesity and bipolar disorder suggested by in silico prediction of functional impact: An analysis in Mexican population.

Authors:  Erasmo Saucedo-Uribe; Alma Delia Genis-Mendoza; Adriana Díaz-Anzaldúa; José Jaime Martínez-Magaña; Carlos Alfonso Tovilla-Zarate; Isela Juárez-Rojop; Nuria Lanzagorta; Michael Escamilla; Thelma Beatriz González-Castro; María Lilia López Narvaez; Yazmín Hernández-Díaz; Humberto Nicolini
Journal:  Brain Behav       Date:  2019-04-29       Impact factor: 2.708

8.  Gata4 and Sp1 regulate expression of the erythropoietin receptor in cardiomyocytes.

Authors:  Sandy von Salisch; Martin Klar; Boris Thurisch; Jörg Bungert; Christof Dame
Journal:  J Cell Mol Med       Date:  2011-09       Impact factor: 5.310

9.  Development of kinomic analyses to identify dysregulated signaling pathways in cells expressing cytoplasmic PrP.

Authors:  Rory H Shott; Cathy Appanah; Catherine Grenier; Guillaume Tremblay; Xavier Roucou; Luis M Schang
Journal:  Virol J       Date:  2014-10-03       Impact factor: 4.099

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.